Zynex, Inc. (NASDAQ: ZYXI) ("Zynex", "ZMS", "we" or the "Company"), an innovative medical technology company specializing in ...

Zynex has completed the clinical verification trial of its pulse oximeter, NiCO, marking a significant milestone towards the ...

The federal and provincial governments are investing more than $24 million to improve local community infrastructure across seven Alberta municipalities. The Town of Okotoks and Foothills County will ...

AbsoluteCare, recognized as a frontrunner in value-based healthcare, is poised to extend its reach into four new markets across two states in 2025: Akron, Dayton and Cincinnati in Ohio and Chicago, ...

HC Wainwright reissued their buy rating on shares of Zynex (NASDAQ:ZYXI – Free Report) in a report issued on Friday morning,Benzinga reports. The brokerage currently has a $17.00 target price on the ...

Zynex (ZYXI) has completed its clinical verification trial for their NiCO pulse oximeter overseen by anesthesiologist Dr. David MacLeod at Duke ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Zynex (ZYXI – Research Report) and KalVista ...

Zynex Inc (NASDAQ:ZYXI) holds a competitive niche in the pain management market, benefiting from its focus on non-invasive, ...

ENGLEWOOD, Colo., Dec. 3, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI) ("Zynex", "ZMS", "we" or the "Company"), an innovative medical technology company ...

ENGLEWOOD, Colo., Dec. 5, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI) ("Zynex", "ZMS", "we" or the "Company"), an innovative medical technology company ...

On Thursday, H.C. Wainwright maintained a positive stance on shares of Zynex Inc. (NASDAQ:ZYXI), reiterating a Buy rating and a $17.00 price target for the company's stock, representing ...